Health Condition 1: null- Type 2 Diabetes
Conditions
Interventions
Control Intervention1: Not Applicable: Not Aplicable
Sponsors
Science and Engineering Research Board SERB
Dr K Satyamoorthy
Dr Sanjiban Chakrabarty
Dr Shashikiran Umakanth
Dr Shivashankara KN
Mr Manik Vohra
Eligibility
Inclusion criteria
Inclusion criteria: Clinically diagnosed drug naïve T2D patients (based on world health organization criteria)
Exclusion criteria
Exclusion criteria: Patients allergic to anti hyperglycemic drugs, type 1 diabetes mellitus, maturity onset diabetes of young (MODYs), gestational diabetes mellitus and secondary diabetes (e.g. pancreatitis, hemochromatosis), clinical renal or hepatic impairment, Cardiac problems (myocardial infarction, unstable angina pectoris), uncontrolled hypertension, non ketotic hyperosmolar coma or chronic diabetic complications, use of medications that could alter glucose metabolism, malignant diseases, hematological diseases, infected with hepatitis virus, psychosis, significant digestion, autoimmune diseases and resorption disturbances acute cerebrovascular accidents within the last 6 months will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The optimization of therapeutic strategy and the potential to expand to patient care.Timepoint: 3 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Better diagnoses, screening and management of diabetic patients in order to achieve individual care should benefit public healthTimepoint: After 3 years | — |
Countries
India
Contacts
Public ContactDr Saadi Abdul Vahab
School of Life Sciences, Manipal University
Outcome results
None listed